In 2006 I moved from the Royal Marsden Hospital to take up the chair of medical oncology at the University of Cambridge. I have developed a large kidney cancer practice with colleagues and continued to develop my interest in early lung cancer and conditions which may become a lung cancer in the future. I have written over 100 peer-reviewed articles and give lectures around the world.
Our kidney cancer clinic has grown enormously over the last 5 years as patients live longer and patients are referred to us from afield. Since 1998, I have developed targeted treatments for kidney cancer which have now become the standard of care. I continue to research new treatments, including ways of activating the immune system against the tumour. I am the chief investigator of a major international adjuvant treatment trial and of several other trials of new treatments in advanced disease. Our laboratory research is focused on understanding the genetic mechanisms underlying disease and developing new biomarkers.
My interests in lung cancer focus on the identification of people at risk of lung cancer and the monitoring and treatment of pre-malignant lung disease which may develop into a cancer.